Get the Stockscreener App
9.86
1.60%
-0.16
After Hours:
9.91
0.05
+0.51%
Corbus Pharmaceuticals Holdings Inc stock is traded at $9.86, with a volume of 57,492.
It is down -1.60% in the last 24 hours and up +10.79% over the past month.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$10.02
Open:
$10
24h Volume:
57,492
Relative Volume:
0.39
Market Cap:
$120.84M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-2.1113
EPS:
-4.67
Net Cash Flow:
$-36.86M
1W Performance:
+5.23%
1M Performance:
+10.79%
6M Performance:
+44.15%
1Y Performance:
-80.58%
1-Day Range:
$9.75
$10.17
1-Week Range:
$9.29
$10.17
52-Week Range:
$4.64
$56.93
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Name
Corbus Pharmaceuticals Holdings Inc
Sector
Industry
Phone
617-963-0103
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
9.86 | 122.80M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Feb-28-25 | Initiated | William Blair | Outperform |
| Dec-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Initiated | Wedbush | Outperform |
| Jul-22-24 | Resumed | H.C. Wainwright | Buy |
| Jun-26-24 | Initiated | B. Riley Securities | Buy |
| Jun-03-24 | Reiterated | Oppenheimer | Outperform |
| May-13-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-06-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-08-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-08-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-08-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-07-20 | Initiated | ROTH Capital | Buy |
| Jun-17-20 | Initiated | BTIG Research | Buy |
| Mar-26-20 | Initiated | Nomura | Buy |
| Apr-05-19 | Initiated | Jefferies | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jan-11-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-26-18 | Initiated | H.C. Wainwright | Buy |
| Dec-07-18 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-18 | Initiated | B. Riley FBR | Buy |
| Jan-19-18 | Initiated | Raymond James | Outperform |
| Dec-14-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-08-17 | Reiterated | Noble Financial | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Mar-30-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-15-16 | Reiterated | JMP Securities | Mkt Outperform |
| Nov-11-16 | Reiterated | Noble Financial | Buy |
View All
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News
Risk vs reward if holding onto Corbus Pharmaceuticals Holdings Inc.Quarterly Earnings Summary & Long-Term Capital Growth Ideas - Newser
What high frequency data says about Corbus Pharmaceuticals Holdings Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - Newser
Nuveen LLC Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. $CRBP - Defense World
Heatmap analysis for Corbus Pharmaceuticals Holdings Inc. and competitorsGap Up & Weekly Momentum Stock Picks - Newser
Published on: 2025-09-05 13:50:22 - Newser
Can Corbus Pharmaceuticals Holdings Inc. recover in the next quarterShort Setup & Accurate Technical Buy Alerts - Newser
Does Corbus Pharmaceuticals Holdings Inc. fit your quant trading modelTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
Will Corbus Pharmaceuticals Holdings Inc. stock recover after recent dropJuly 2025 Setups & Verified Technical Trade Signals - Newser
Is Corbus Pharmaceuticals Holdings Inc. still worth holding after the dipWeekly Trend Recap & Free Technical Pattern Based Buy Signals - Newser
Corbus Pharmaceuticals Holdings Inc. stock trend outlook and recovery pathSwing Trade & Free Weekly Watchlist of Top Performers - Newser
Momentum divergence signals in Corbus Pharmaceuticals Holdings Inc. chartMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
How to track smart money flows in Corbus Pharmaceuticals Holdings Inc.2025 Risk Factors & Weekly Setup with ROI Potential - Newser
What is the earnings history of Corbus Pharmaceuticals Holdings Inc.2025 Short Interest & Entry and Exit Point Strategies - خودرو بانک
Is it too late to sell Corbus Pharmaceuticals Holdings Inc.Earnings Risk Report & Fast Gain Swing Alerts - Newser
Reversal indicators forming on Corbus Pharmaceuticals Holdings Inc. stockPortfolio Growth Summary & Risk Managed Investment Signals - Newser
Live market analysis of Corbus Pharmaceuticals Holdings Inc.July 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
Forecasting Corbus Pharmaceuticals Holdings Inc. price range with options dataQuarterly Trade Summary & Risk Managed Investment Entry Signals - Newser
How to interpret RSI for Corbus Pharmaceuticals Holdings Inc. stock2025 Performance Recap & Fast Momentum Entry Tips - Newser
Can momentum traders help lift Corbus Pharmaceuticals Holdings Inc.Weekly Earnings Recap & Safe Entry Point Identification - Newser
Published on: 2025-09-03 00:52:59 - Newser
Is Corbus Pharmaceuticals Holdings Inc. stock bottoming outShare Buyback & Daily Volume Surge Trade Alerts - Newser
What’s the recovery path for long term holders of Corbus Pharmaceuticals Holdings Inc.July 2025 Snapshot & Weekly Watchlist for Hot Stocks - Newser
Exit strategy if you’re trapped in Corbus Pharmaceuticals Holdings Inc.July 2025 Volume & Community Consensus Picks - Newser
Published on: 2025-09-02 03:48:22 - Newser
Published on: 2025-09-02 03:06:02 - Newser
What is the next catalyst for Corbus Pharmaceuticals Holdings Inc.Weekly Trend Summary & Fast Gain Swing Alerts - خودرو بانک
Can you recover from losses in Corbus Pharmaceuticals Holdings Inc.July 2025 Retail & Technical Confirmation Trade Alerts - Newser
Published on: 2025-09-01 14:00:19 - Newser
Is this a good reentry point in Corbus Pharmaceuticals Holdings Inc.Earnings Overview Summary & Fast Exit and Entry Trade Guides - Newser
Death Cross: How do insiders feel about Corbus Pharmaceuticals Holdings Inc.Profit Target & Weekly Return Optimization Alerts - خودرو بانک
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant found a price floorStock Surge & Weekly High Return Stock Opportunities - Newser
Volatility clustering patterns for Corbus Pharmaceuticals Holdings Inc.July 2025 Movers & Low Drawdown Momentum Ideas - Newser
Corbus Pharmaceuticals Holdings Inc. stock trend forecastEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
How to recover losses in Corbus Pharmaceuticals Holdings Inc. stockEarnings Beat & Community Supported Trade Ideas - Newser
Does Corbus Pharmaceuticals Holdings Inc. show high probability of reboundTrade Signal Summary & Daily Profit Focused Stock Screening - Newser
Sector ETF performance correlation with Lument Finance Trust Inc.Weekly Profit Report & Free Weekly Chart Analysis and Trade Guides - Newser
Tools to assess Corbus Pharmaceuticals Holdings Inc.’s risk profileMarket Risk Summary & Fast Moving Market Watchlists - Newser
Published on: 2025-08-31 10:56:23 - beatles.ru
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):